CPT code 53866 denotes the endoscopic removal of a temporary device from the prostatic urethra that compresses prostate tissue to induce ischemia and improve urine flow. This procedure is relevant nationally as a minimally invasive option for relieving lower urinary tract obstruction related to prostatic tissue, offering an alternative to more invasive surgical approaches. It has implications for surgical pathway planning, outpatient procedural capacity, and device-related care coordination.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for CPT code 53866, how the service is typically delivered and where it is performed, and what to expect in terms of coding and billing themes. The publication summarizes common modifiers and payer considerations when available, highlights benchmarks where provided, and outlines policy and coding updates that affect national coverage and reimbursement patterns.

This national-level summary is intended for health system billing managers, coding professionals, and clinicians involved in procedural urology. It provides the essential clinical and administrative context needed to align coding practice with operational and payer requirements.